Silver sulfide coated alginate radioenhancer for enhanced X-ray radiation therapy of breast cancer

Int J Biol Macromol. 2023 Apr 15:234:123636. doi: 10.1016/j.ijbiomac.2023.123636. Epub 2023 Feb 11.

Abstract

A wide range of high-Z nanomaterials are fabricated to decrease radiation dose by sensitizing cells to irradiation through various mechanisms such as ROS generation enhancement. Alginate-coated silver sulfide nanoparticles (Ag2S@Alg) were synthesized and characterized by SEM, TEM, DLS, XRD, EPS, FT-IR, and UV-vis analysis techniques. Cytotoxicity of nanoparticles was tested against HFF-2, MCF-7, and 4 T1 cell lines for biocompatibility and radio enhancement ability evaluation, respectively. Moreover, the hemolysis assay demonstrated that the nanoparticles were biocompatible and nontoxic. In vitro intracellular ROS generation and calcein AM/PI co-staining unveiled cancerous cell death induction by nanoradiosensitizer, Ag2S@Alg. Further, histopathology results emphasized the tumor ablation capability of Ag2S@Alg. Silver anticancer properties were also recognized and combined with its radiosensitizing effect under X-ray irradiation.

Keywords: Alginate; Breast Cancer; Nanoparticle; Radiosensitizer; Radiotherapy; Silver.

MeSH terms

  • Alginates
  • Breast Neoplasms* / pathology
  • Breast Neoplasms* / radiotherapy
  • Female
  • Humans
  • Metal Nanoparticles* / therapeutic use
  • Reactive Oxygen Species
  • Spectroscopy, Fourier Transform Infrared
  • X-Rays

Substances

  • Alginates
  • silver sulfide
  • Reactive Oxygen Species